oxymetazoline has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, J | 1 |
| Yang, D | 1 |
1 other study available for oxymetazoline and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline.
Topics: Aged; Blepharoptosis; Eyelids; Female; Humans; Myasthenia Gravis; Oxymetazoline; Visual Fields | 2021 |